ArticleCase reports in women's health2026
A 6.3 kg uterine tumor resembling an ovarian sex cord-stromal tumor (UTROSCT): A case report.
Article in Case reports in women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Uterine tumor resembling ovarian sex cord-stromal tumor (UTROSCT) is a rare uterine neoplasm characterized by sex cord-like differentiation. Although typically indolent and confined to the uterus, UTROSCT can occasionally exhibit atypical clinical and pathological behavior, complicating preoperative diagnosis. A 52-year-old postmenopausal woman (G3P3A0) with no significant medical history presented with a painless umbilical swelling persisting for eight months. Physical and radiological assessment revealed a paraumbilical hernia and she was scheduled for elective laparoscopic repair. Intraoperatively, a large amount of viscous gelatinous material was unexpectedly discovered in the peritoneal cavity, with no visible peritoneal or visceral mass. Peritoneal biopsies and cytology suggested a low-grade neoplasm of uncertain origin, initially raising suspicion of pseudomyxoma peritonei (PMP). Computed tomography showed a large soft-tissue lesion occupying the lower abdomen and pelvic cavity, extending to the umbilicus and supplied by a branch of the uterine artery. Multidisciplinary tumor board discussion favored a uterine source, and cytoreductive surgery with total hysterectomy and peritonectomy was performed. A 40 cm encapsulated gelatinous uterine mass weighing 6.3 kg was excised. Histopathology and immunohistochemistry confirmed UTROSCT with positivity for sex cord markers and hormone receptors. Margins were negative and there was no lymphovascular invasion. The postoperative course was uneventful. The patient received adjuvant tamoxifen therapy and remained disease-free during 48 months of follow-up. This case illustrates an exceedingly rare presentation of UTROSCT, with much large tumor size than previously reported.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.